Precision Health Clinical Trials

Clinical Trial Multi-analyte Blood Test

Condition:   Liver Cirrhosis
Intervention:   Diagnostic Test: Multi-analyte blood Test
Sponsor:   Helio Genomics
Recruiting

For more information, visit the Study URL.

Establishment of Molecular Classification Models for Early Diagnosis of Digestive System Cancers

Conditions:   Esophageal Cancer;   Gastric (Stomach) Cancer;   Colorectal Cancer;   Hepatocellular Carcinoma
Intervention:  
Sponsors:   Singlera Genomics Inc.;   Fudan University;   Shanghai Public Health Clinical Center;   Xuhui Central Hospital, Shanghai;   Shanghai Zhongshan Hospital
Recruiting

For more information, visit the Study URL.

Testing Olaparib and Temozolomide Versus the Usual Treatment for Uterine Leiomyosarcoma After Chemotherapy Has Stopped Working

Conditions:   Locally Advanced Leiomyosarcoma;   Locally Advanced Uterine Corpus Leiomyosarcoma;   Metastatic Leiomyosarcoma;   Metastatic Uterine Corpus Leiomyosarcoma;   Stage III Uterine Corpus Leiomyosarcoma AJCC v8;   Stage IV Uterine Corpus Leiomyosarcoma AJCC v8;   Unresectable Leiomyosarcoma;   Unresectable Uterine Corpus Leiomyosarcoma;   Uterine Corpus Leiomyosarcoma
Interventions:   Drug: Olaparib;   Drug: Pazopanib;   Drug: Temozolomide;   Drug: Trabectedin
Sponsor:   National Cancer Institute (NCI)
Not yet recruiting

For more information, visit the Study URL.

Assessment the Cancer Risk of Indeterminate Thyroid Nodules Through Integration of Clinical, Ultrasonographic and Multiomic Features

Conditions:   Thyroid Nodule;   Thyroid Cancer
Intervention:   Diagnostic Test: Multiomic analyses of blood and surgical specimens
Sponsors:   University of Cagliari;   Prof. Pietro Giorgio Calò;   Dott. Gian Luigi Canu
Not yet recruiting

For more information, visit the Study URL.

Pneumococcal Carriage and Serotype Distribution in Children With Otitis Media in Malaysia.

Conditions:   Streptococcus Pneumonia;   Otitis Media
Intervention:  
Sponsors:   International Medical University;   International Islamic University Malaysia;   Universiti Putra Malaysia;   University of Southampton;   Merck Sharp & Dohme LLC;   Hospital Serdang
Recruiting

For more information, visit the Study URL.

Precise Therapy for Refractory HER2 Positive Advanced Breast Cancer

Condition:   HER2+ Breast Cancer
Interventions:   Drug: Trastuzumab;   Drug: Pertuzumab;   Drug: Nab paclitaxel;   Drug: Pyrotinib;   Drug: Capecitabine;   Drug: T-DM1;   Drug: Everolimus;   Drug: CDK4/6 inhibitor;   Drug: AI;   Drug: Anti-PD-1 monoclonal antibody
Sponsor:   First Affiliated Hospital Xi'an Jiaotong University
Recruiting

For more information, visit the Study URL.

The Analysis of Gene Variants Related to POCD in Elderly Patients

Condition:   Cognitive Dysfunction
Intervention:   Procedure: Urologic Surgery
Sponsor:   Istanbul University
Not yet recruiting

For more information, visit the Study URL.

Prediction of Postoperative Treatment Efficacy and Recurrence Risk of High-risk GIST Based on Minimal Residual Disease Detected by Liquid Biopsy

Conditions:   Gastrointestinal Stromal Tumors;   Minimal Residual Disease
Intervention:   Diagnostic Test: liquid biopsy
Sponsor:   Peking University People's Hospital
Recruiting

For more information, visit the Study URL.

Marathon of Hope Cancer Centres Network Study for Ontario (MOHCCN-O)

Conditions:   Breast Cancer;   Colorectal Cancer;   Pancreas Cancer;   Kidney Cancer;   Prostate Cancer;   Ovary Cancer;   Head and Neck Cancer;   Leukemia;   Lymphoma;   Lung Cancer;   Melanoma;   Solid Tumor
Intervention:  
Sponsors:   University Health Network, Toronto;   Princess Margaret Hospital, Canada;   Ontario Institute for Cancer Research;   Terry Fox Research Institute
Recruiting

For more information, visit the Study URL.

Diabetic Ketoacidosis From New SGLT2i: Can Genomics Estimate Risk

Conditions:   Diabetes Type 2;   DKA;   Diabetic Ketoacidosis
Intervention:   Genetic: Genomic analysis
Sponsors:   Mount Sinai Hospital, Canada;   Unity Health Toronto;   University Health Network, Toronto;   Sault Area Hospital
Recruiting

For more information, visit the Study URL.

Pages